Studies on the mechanism of action of bendazac (AF 983).
D000085:Acetates / Q000032:analysis / Q000494:pharmacology*; D000818:Animals; D000893:Anti-Inflammatory Agents / Q000494:pharmacology*; D001797:Blood Protein Electrophoresis; D003720:Densitometry; D003956:Dialysis; D005260:Female; D006358:Hot Temperature; D006854:Hydrocortisone / Q000494:pharmacology*; D008297:Male; D009824:Ointments; D010047:Ovalbumin; D010653:Phenylbutazone / Q000494:pharmacology*; D011485:Protein Binding / Q000187:drug effects*; D011489:Protein Denaturation / Q000187:drug effects*; D011720:Pyrazoles / Q000032:analysis / Q000494:pharmacology*; D011817:Rabbits; D011837:Radiation-Protective Agents / Q000494:pharmacology; D051381:Rats; D012710:Serum Albumin, Bovine; D012867:Skin / Q000032:analysis; D012869:Skin Absorption; D014466:Ultraviolet Rays; D014822:Vitreous Body / Q000032:analysis
D000085:Acetates; D000893:Anti-Inflammatory Agents; D009824:Ointments; D011720:Pyrazoles; D011837:Radiation-Protective Agents; D012710:Serum Albumin, Bovine; D010047:Ovalbumin; D010653:Phenylbutazone; D006854:Hydrocortisone